Avoiding perioperative dexamethasone may improve the outcome of patients with rectal cancer

European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology
H C YuJ P Wang

Abstract

Perioperative administration of dexamethasone may augment recurrence and mortality after tumor resection possibly by immunosuppression, which, unfortunately, has never been noted. We therefore carried out a retrospective study in rectal cancer to validate the hypothesis. Five hundreds and fifteen patients with stage I to III rectal cancers who underwent a curative resection from June 2007 and June 2011 were enrolled in the current study. Patients who had been given intravenous (IV) dexamethasone (4-10 mg) postoperatively and/or intraoperatively were assigned to dexamethasone group. The outcome of dexamethasone group and non-dexamethasone group were compared. The primary outcome was disease-free survival (DFS) and overall survival (OS). dexamethasone group had significant lower three-year DFS (62.3% vs 71.8%, P = 0.026) and OS (74.1% vs 82.9%, P = 0.031) rate in comparison to non-dexamethasone group, the hazard ratios (HRs) of which were 1.59 (95% CI 1.05-2.39, P = 0.028) and 1.77 (95% CI 1.05-3.01, P = 0.034), respectively. Multivariate analysis revealed that administration of systemic dexamethasone were independently associated with DFS [adjusted HR 1.60 (95% CI 1.03-2.49, p = 0.039)], but for OS, dexamethasone didn't remain s...Continue Reading

Associated Clinical Trials

References

Jan 1, 1987·European Journal of Clinical Pharmacology·M E BradyC T Bauguess
Jan 1, 1980·Journal of Surgical Oncology·J Lundy
May 13, 1993·The New England Journal of Medicine·O R BuschJ Jeekel
Jan 1, 1994·American Journal of Surgery·T A ColacchioL W Hildebrandt
Jan 1, 1996·The Journal of Allergy and Clinical Immunology·L M SchwiebertL A Schwiebert
Jan 1, 2005·Current Opinion in Oncology·Olga Frankfurt, Steven T Rosen
Jan 25, 2012·Current Opinion in Anaesthesiology·Trevor Kavanagh, Donal J Buggy
Jan 4, 2013·British Journal of Anaesthesia·A Heaney, D J Buggy

❮ Previous
Next ❯

Citations

Aug 10, 2016·Surgery Research and Practice·Dario BugadaGuido Fanelli
Oct 9, 2019·Der Anaesthesist·B Sinner
Apr 15, 2020·International Journal of Molecular Sciences·Silvia ZappavignaMichele Caraglia

❮ Previous
Next ❯

Related Concepts

Related Feeds

Adenomatous Polyposis Coli

Adenomatous polyposis coli is a protein encoded by the APC gene and acts as a tumor suppressor. Discover the latest research on adenomatous polyposis coli here.

Cancer Imaging

Imaging techniques, including CT and MR, have become essential to tumor detection, diagnosis, and monitoring. Here is the latest research on cancer imaging.

Allergy and Asthma

Allergy and asthma are inflammatory disorders that are triggered by the activation of an allergen-specific regulatory t cell. These t cells become activated when allergens are recognized by allergen-presenting cells. Here is the latest research on allergy and asthma.